Call(WhatsApp Us)
+8618988990383Email Us
postmaster@laeyolabs.com广州市花都区花山镇华辉路18号
微观化妆品创意产业园E栋整栋When sourcing or manufacturing eye care products, regulatory documentation is not optional—it’s the foundation of compliance, safety, and market approval. Two core documents often requested by buyers or regulators are the Certificate of Analysis…
When sourcing or manufacturing eye care products, regulatory documentation is not optional—it’s the foundation of compliance, safety, and market approval. Two core documents often requested by buyers or regulators are the Certificate of Analysis (COA) and the Safety Data Sheet (SDS, formerly MSDS). Understanding the difference, what each proves, and the point in your procurement timeline to request them can prevent costly delays or product rejections.
| Document | Primary Focus | When Needed | Proof Type |
|---|---|---|---|
| COA | Quality verification of a specific batch | Pre-shipment, post-production | Measured results vs. specifications |
| SDS | Hazard communication & safe handling | Supplier onboarding, regulatory filings, logistics | Regulatory hazard classification and mitigation steps |
Yes—COA is critical for batch release, while SDS is mandated for safety compliance and hazard communication.
No. They serve distinct functions; COA verifies technical quality, SDS ensures safe handling and hazard disclosure.
The manufacturer or raw material supplier issues these. In some cases, third-party labs may issue COAs after independent testing.
Whenever there is a formulation change, regulatory classification change, or at least every five years depending on jurisdiction.
Even for non-hazardous classifications, an SDS is generally expected to document the safety assessment and regulatory status.
Request a Quote to align your eye care sourcing with the right documentation at the right time.